Advos

Greenland Energy Company progresses toward an October 2026 exploration drilling campaign in East Greenland's Jameson Land Basin, with potential billions of barrels in oil resources that could impact energy security and Greenland's economy.

Onco-Innovations Ltd. is pushing cancer nanomedicine forward with its lead candidate ONC010, a PNKP inhibitor paired with a polymer nanodelivery system, as the field sees renewed optimism with over 20 approved formulations.

Researchers from King's College London and McMaster University have discovered a molecular pathway critical for cancer migration to the brain, potentially revolutionizing treatment for metastatic disease.

DNA Damage Response inhibitors, already generating over $7 billion in sales in 2025, are expanding beyond PARP inhibitors, with companies like Onco-Innovations developing novel PNKP inhibitors targeting multiple repair pathways.

A new study reveals that excessive dependence on AI tools like ChatGPT could impair critical thinking, highlighting the need for balanced use, even as companies like Core AI Holdings Inc. leverage AI for cognitive enhancement in gaming.

Gold and silver prices have risen significantly, with gold reaching $4,362 per ounce and silver hitting $71.2 per ounce, driven by four key factors that could impact investors and the mining industry.

Quantum BioPharma is developing Lucid-MS, a first-in-class drug candidate aimed at repairing myelin sheaths in multiple sclerosis patients, as it prepares for phase 2 clinical trials amidst a landscape where existing treatments only slow disease progression.

Functional beverages are becoming a mainstream daily habit, driven by consumer demand for clean ingredients, convenience, and integration into everyday routines rather than reactive wellness.

Quantum BioPharma Ltd. is progressing its novel drug candidate Lucid-MS, designed to protect myelin sheaths damaged by multiple sclerosis, toward Phase 2 clinical trials after filing an Investigational New Drug application with the FDA.

Beeline Holdings Inc. (NASDAQ: BLNE) has been added to the Russell Microcap Index, highlighting its growth in AI-driven mortgage lending and increased institutional visibility.

Onco-Innovations Limited is advancing ONC010, a nanoparticle-encapsulated PNKP inhibitor, into the growing DNA damage response oncology market, which generated over $7 billion in 2025, with potential impact on colorectal cancer and other solid tumors.

Cardio Diagnostics Holdings announces that Atlas Healthcare Physicians will provide coverage for its AI-powered coronary heart disease tests, expanding precision medicine access to managed care populations in Los Angeles and Orange counties.

Mighty Sesame Co. is capitalizing on consumer demand for convenient, versatile plant-based ingredients by offering ready-to-use squeeze-bottle tahini, reflecting broader food industry trends toward simplicity and ingredient transparency.

Massimo Group (NASDAQ: MAMO) has terminated its proposed acquisition of FST Development Company Limited to refocus on its internal development of intelligent security technologies, supported by up to $4 million in funding from its controlling shareholder.

Gaxos.ai divests its gaming assets to Game Foundry AI for about $1.76 million in stock, aiming to concentrate on higher-margin AI opportunities.

HH Red Stone warns that property management companies that lose sight of resident experience face declining urgency, reputation, and financial performance, urging a resident-first operating philosophy.

Rail Vision Ltd. announced successful field testing of its ShuntingYard system with Israel Railways, leading to discussions for potential commercialization and expanding its reach through a recent partnership with Railserve.

Onco-Innovations Limited has engaged Nanosoft Polymers to advance its lead nanoparticle-formulated PNKP inhibitor, ONC010, focusing on scalable manufacturing and IND-enabling development.

Ladybug Resource Group's Jingdiao division deepens its strategic alliance with global automation integrator Mino, supplying precision components for next-gen electric vehicle manufacturing lines serving Tesla, Volkswagen, BMW and other major OEMs.

Helus Pharma has priced a $50 million public offering to fund Phase 3 trials for its depression treatment and other pipeline candidates.

Silvercorp Metals announced a 59% increase in measured and indicated mineral resource tonnage at its Gaocheng mine, with plans to boost annual throughput and extend mine life through 2041.